Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05714761 · ClinicalTrials.gov registry record · NA
Postpartum Continuous Glucose Monitoring (CGM) Study
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05714761 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 50 participants.
The verdict
NCT05714761, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This research study is being done to assess if using a glucose sensor (also known as a continuous glucose monitor) after childbirth can help identify women who are at risk of developing diabetes after having diabetes during pregnancy or gestational diabetes. Currently, screening for diabetes after childbirth is performed with an oral glucose tolerance test 6-12 weeks after delivery, but this is burdensome. This study will use a glucose sensor worn on the skin for 10 days. The data from the sensor will be compared to the standard oral glucose tolerance test. This is a single site study at the Icahn School of Medicine at Mount Sinai. The research team plans to enroll 50 participants aged 18years or older into the study. Participation in the study is expected to last up to 20 weeks and involves 4-5 visits depending on if enrollment is in the 3rd trimester of pregnancy or immediate postpartum. Study procedures include 1. Consent \& screening. 2.Sensor placement and download after 10 days of wear. 3. a second sensor placement 2-5 days before oral glucose tolerance test (OGTT).
Interventions
- DEVICE Dexcom glucose sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-02-16 |
| Est. Completion | 2024-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05714761
The ClinicalTrials.gov registry entry for NCT05714761 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexcom glucose sensor is the first listed.
NCT05714761 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05714761 about?
NCT05714761 is a clinical study titled "Postpartum Continuous Glucose Monitoring (CGM) Study". This research study is being done to assess if using a glucose sensor (also known as a continuous glucose monitor) after childbirth can help identify women who are at risk of developing diabetes after having diabetes during pregnancy or gestational diabetes. Currently, screening for diabetes after c...
What is the current status of trial NCT05714761?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-02-16. Estimated completion is 2024-03-08.
What interventions are being tested in trial NCT05714761?
The interventions under investigation include: Dexcom glucose sensor (DEVICE).
Who is sponsoring clinical trial NCT05714761?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.